A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
During this fireside we welcome Unicycive Therapeutics. Unicycive (Nasdaq: UNCY) is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead drug candidate, oxylanthanum carbonate (OLC), is a novel investigational phosphate binding...
In this presentation, we welcome Unicycive Therapeutics, Nasdaq ticker symbol UNCY. And with us today is their Chairman and CEO, Shalabh Gupta. Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. This Fireside Chat was...